Clinical Trial Update: Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Extraneal (icodextrin) and triglyceride levels in peritoneal dialysis patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertriglyceridemia

Drugs mentioned

• Extraneal (icodextrin)

Snippet

Sponsor: Vantive Health LLC | Conditions: Peritoneal Dialysis, Hypertriglyceridemia | Phase 4 | Status: WITHDRAWN